16.68
+0.40
+(2.46%)
At close: January 29 at 4:00:02 PM EST
16.90
+0.22
+(1.32%)
Pre-Market: 9:03:02 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 2 | 4 | 4 |
| Avg. Estimate | -0.58 | 0.63 | 0.09 | 0.65 |
| Low Estimate | -0.68 | 0.44 | 0.09 | 0.25 |
| High Estimate | -0.48 | 0.83 | 0.1 | 0.88 |
| Year Ago EPS | -0.66 | 0.62 | -1.22 | 0.09 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 4 | 6 | 6 |
| Avg. Estimate | 2.47B | 2.79B | 9.26B | 11.69B |
| Low Estimate | 2.45B | 2.69B | 9.23B | 10.88B |
| High Estimate | 2.5B | 2.92B | 9.28B | 12.69B |
| Year Ago Sales | 1.43B | 2.14B | 5.87B | 9.26B |
| Sales Growth (year/est) | 72.68% | 30.31% | 57.84% | 26.30% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.7 | 0.27 | 0.16 | -0.18 |
| EPS Actual | -0.66 | 0.62 | 0.2 | -0.22 |
| Difference | 0.04 | 0.35 | 0.05 | -0.04 |
| Surprise % | 6.38% | 129.63% | 29.03% | -25.04% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.58 | 0.63 | 0.09 | 0.65 |
| 7 Days Ago | -0.58 | 0.63 | 0.09 | 0.65 |
| 30 Days Ago | 0 | 0.62 | 0.09 | 0.65 |
| 60 Days Ago | -0.55 | 0.64 | 0.08 | 0.63 |
| 90 Days Ago | -0.55 | 0.64 | 0.08 | 0.63 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 2 | 1 | 2 | 2 |
| Down Last 7 Days | 2 | 1 | -- | 1 |
| Down Last 30 Days | 3 | -- | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OSCR | 11.78% | 2.42% | 107.50% | 609.66% |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Initiated | Jefferies: Underperform | 12/10/2024 |
| Downgrade | B of A Securities: Neutral to Underperform | 11/6/2024 |
| Initiated | UBS: Neutral | 10/7/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 9/10/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 8/8/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 7/10/2024 |
Related Tickers
CLOV Clover Health Investments, Corp.
4.4500
-3.05%
ALHC Alignment Healthcare, Inc.
15.32
+0.66%
HUM Humana Inc.
294.23
-2.93%
ELV Elevance Health, Inc.
400.30
-1.26%
CVS CVS Health Corporation
56.90
-0.75%
UNH UnitedHealth Group Incorporated
538.10
-0.81%
MOH Molina Healthcare, Inc.
304.28
-1.02%
CI The Cigna Group
303.31
+0.16%
CNC Centene Corporation
63.91
-1.25%
NEUE NeueHealth, Inc.
7.34
-0.14%